97342 ⎘
Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#302Asparaginase and treating diseases associated with asparagine dependence
#303Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#304Bispecific anti-EGFR/anti IGF-1R antibodies
#305Amino acid sequence presenting fusion polypeptide and its use
#306GPCR comprising an IC2 insertion
#307WDR13 as a novel biomarker useful for treating diabetes and cancer
#308Wnt compositions and therapeutic uses of such compositions
#309Modified laminin and use thereof
#310Antibody specifically binding to insulin-like growth factor-1
#311Polynucleotides encoding extracellular-signal-regulated kinase (ERK) heteropolyligand polypeptides
#312Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#313High affinity antibody antagonists of interleukin-13 receptor alpha 1
#314Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
#315Method for producing epithelial stem cells
#316Methods for identifying and isolating cells expressing a polypeptide
#317Methods for identifying and isolating cells expressing a polypeptide
#318BLID; a novel protein domain for interaction with the Bcl-2 family of proteins
#319Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region
#320Systems for factor VIII processing and methods thereof
#321EGFR-related polypeptides and methods of use
#322Alternative splicing variant of OATP1B3 mRNA
#323Binding molecules for BCMA and CD3
#324Binding molecules for BCMA and CD3
#325Preparation and/or purification of oligonucleotide conjugates
#326MEANS AND METHODS FOR IMPROVING THE DEVELOPMENT AND MATURATION OF EGGS AND/OR SPERM IN FISH USING HORMONES PRODUCED BY TRANSPLANTED CELLS
#327Isolated laminin-421
#328NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#329Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides
#330PEPTIDE DISPLAY ARRAYS
#331RADIOLABELED COMPOUND DIRECTABLE IN VIVO TO TARGET TISSUE AND USE THEREOF
#332CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#333GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#334CONSTRUCTS THAT ALLOW FOR DETECTION AND QUANTITATION OF MEMBRANE PROTEINS
#335Covalent tethering of functional groups to proteins and substrates therefor
#336GPCR comprising an IC2 insertion
#337Endoglucanase variants
#338Erythrocyte-binding therapeutics
#339Method for purifying albumin
#340PHARMACEUTICAL COMPOSITION CONTAINING NUCLEAR FACTOR INVOLVED IN PROLIFERATION AND DIFFERENTIATION OF CENTRAL NEURONAL CELLS
#341Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#342Compositions and methods for identifying enzyme and transport protein inhibitors
#343Erythrocyte-binding therapeutics
#344Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)
#345Mucin derived polypeptides
#346Alternative splicing variant of OATP1B3 mRNA
#347BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#348Methods for identifying and isolating cells expressing a polypeptide
#349AKT ligands and polynucleotides encoding AKT ligands
#350Peptides for inhibiting the HPV-E6 oncoprotein
#351Covalent tethering of functional groups to proteins and substrates therefor
#352METHODS FOR PRODUCTION OF UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF
#353Phage display using cotranslational translocation of fusion polypeptides
#354Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
#355COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#356Increased T-cell tumor infiltration and eradication of metastases by mutant light
#357REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS
#358Targeted modification of chromatin structure
#359Regulated apoptosis
#360METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#361PROCESS FOR THE PRODUCTION OF A PEPTIDE
#362Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors
#363High affinity antibody antagonists of interleukin-13 receptor alpha 1
#364PRODUCTION AND USE OF EPITOPE-TAGGED HEPATITIS C VIRUS PARTICLE
#365Recombinant baculovirus vaccine
#366y134.5 Deficient HSV and the MAPK Pathway
#367CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS
#368Methods for protein labeling based on acyl carrier protein
#369Nucleic acid modules for expression and tagging of membrane proteins and methods of use
#370COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS
#371Soluble IL-17RCx4 and fusion proteins thereof
#372Epitope-tag surface expressed proteins and nucleic acids thereof
#373Novel Vectors for Production of Interferon
#374RECOMBINANT ANTIGENS OF HUMAN CYTOMEGALOVIRUS (HCMV)
#375Protein having an EGF-like repeat sequence
#376Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
#377ALTERED VIRUS CAPSID PROTEIN AND USE THEREOF
#378Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
#379Protein and production process and use thereof
#380AKT ligands and polynucleotides encoding AKT ligands
#381Selection system
#382Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
#383Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
#384Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
#385Selection
#386Avian leukosis viruses and polypeptide display
#387MOLECULE AND CHIMERIC MOLECULES THEREOF
#388Tagged IgA1 proteases
#389Increased T-cell tumor infiltration and eradication of metastases by mutant light
#390Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
#391Regulated transcription of targeted genes and other biological events
#392BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS
#393Compositions and methods for identifying transforming and tumor suppressor genes
#394Combination therapy with IgA1 proteases
#395Targeted modification of chromatin structure
#396Viral Vectors
#397Methods and compositions for the detection and isolation of ligands
#398Live attenuated antigenically marked classical swine fever virus
#399Methods for production of unstructured recombinant polymers and uses thereof
#400Polynucleotides encoding proteins for covalent tethering to functional groups and substrates
#401Modifier of Organelle Metabolism
#402HER-2/neu fusion proteins
#403Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
#404High affinity antibody antagonists of interleukin-13 receptor alpha 1
#405Means and Methods for Improving the Development and Maturation of Eggs and/or Sperm in Fish Using Hormones Produced by Transplanted Cells
#406Recombinant protein and method of screening for agents that modulate polypeptide aggregation
#407Means for stimulation and activation of hair growth by il-15
#408Chemokine receptor materials and methods
#409Method for decreasing blood glucose and improving glucose tolerance using angiopoietin-like protein 4
#410Methods and compositions comprising GFP
#411Human pellino polypeptides
#412Method of treating inflammation using soluble IL-17RCX4
#413Modified HPV E6 and E7 genes and proteins useful for vaccination
#414MODIFIED HPV E6 AND E7 GENES AND PROTEINS USEFUL FOR VACCINATION
#415Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with SARS corona virus spike protein
#416Pharmacokinetic modulation and compositions for modified FN3 polypeptides
#417Inhibitors of type 2 vascular endothelial growth factor receptors
#418Method of producing target protein, fusion protein and gene thereof, protein consisting of partial sequence of intein and gene thereof, expression vector, and transformant
#419Methods for protein labeling based on acyl carrier protein
#420Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
#421Avian leukosis viruses and polypeptide display
#422Probes for analyzing interaction between proteins and method of analyzing interaction between proteins using the same
#423Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections
#424Methods and compositions for modulating the interaction between adiponectin and its receptor
#425Methods and compositions for treatment of viral lnfection
#426Methods and compositions for inhibiting stat signaling pathways
#427Targeted modification of chromatin structure
#428Method of screening for improved specific activity of enzymes
#429Membrane penetrating peptides and uses thereof
#430Purification of recombinant proteins fused to multiple epitopes
#431Regulated transcription of targeted genes and other biological events
#432Uses of agonists and antagonists to modulate activity of TNF-related molecules
#433Compositions and methods for protein production
#434Regulated apoptosis
#435Covalent tethering of functional groups to proteins and substrates therefor
#436Therapeutic and diagnostic proteins comprising a SOCS box
#437Compositions and methods related to a dimeric MHC class I and II-Like molecule (dsMHCI and dsMHCII)
#438Ablated SLAM-Dependent Entry
#439Method of screening for modulators of HIV infection
#440Immunoglobulin chimeric monomer-dimer hybrids
#441Regulation of endogenous gene expression in cells using zinc finger proteins
#442Rapid and enzymeless cloning of nucleic acid fragments
#443Modified annexin proteins and methods for preventing thrombosis
#444Streptavidin-binding peptides and uses thereof
#445Populations of cells that express flk-2 receptors
#446Treatment of IgA1 deposition diseases
#447BAFF variants and methods thereof
#448Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
#449Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
#450Rapidly cleavable SUMO fusion protein expression system for difficult to express proteins
#451Inhibitors of apoptosis
#452Use of chimeric nucleases to stimulate gene targeting
#453HIV-1 envelope glycoproteins having unusual disulfide structure
#454Increased T-cell tumor infiltration by mutant LIGHT
#455Populations of cells that express FLK-1 receptors